Infectious Disease Book

//fpnotebook.com/

Atovaquone

Aka: Atovaquone, Mepron, Malarone
  1. Indications
    1. Human Immunodeficiency Virus (HIV)
      1. Pneumocystis carinii Pneumonia prophylaxis
      2. Pneumocystis carinii Pneumonia treatment
      3. Patients unable to tolerate Bactrim
    2. Malaria Prophylaxis and Treatment (Malarone)
      1. Third line agent (Mefloquine preferred)
    3. Babesiosis
  2. Contraindications
    1. Creatinine Clearance <30 ml/minute/1.73m2
    2. Pregnancy Category C
    3. Breast Feeding of infants under 11 klb (5 kg)
  3. Dosing: Pneumocystis carinii Pneumonia
    1. Prophylaxis: 1500 mg PO qd with food
    2. Treatment: 750 mg PO bid with food for 21 days
  4. Dosing: Malaria (Atovaquone/Proguanil or Malarone)
    1. Adults
      1. Prophylaxis: 1 tablet (250 mg/100 mg) orally daily
        1. Start 1-2 days before travel
        2. Stop 7 days after return
      2. Treatment: 4 tablets (1000 mg/400 mg) orally daily for 3 days
    2. Children (over age 1 month)
      1. Weight 5-8 kg
        1. Prophylaxis: 1/2 tablet (62.5 mg /25 mg) orally daily
      2. Weight 9-10 kg
        1. Prophylaxis: 3/4 tablet (62.5 mg /25 mg) orally daily
      3. Weight: 11-20 kg
        1. Prophylaxis: 1 tablet (62.5 mg /25 mg) orally daily
        2. Treatment: 1 tablet (250 mg/100 mg) orally daily
      4. Weight: 21-30 kg
        1. Prophylaxis: 1 tablet (125 mg /50 mg) orally daily
        2. Treatment: 2 tablet (250 mg/100 mg) orally daily
      5. Weight: 31-40 kg
        1. Prophylaxis: 1 tablet (187.5 mg /75 mg) orally daily
        2. Treatment: 3 tablet (250 mg/100 mg) orally daily
      6. Weight: >40 kg (Adult dose)
        1. Prophylaxis: 1 tablet (250 mg /100 mg) orally daily
        2. Treatment: 4 tablet (250 mg/100 mg) orally daily
  5. Precautions: Poor absorption
    1. Take with food (fatty meal) to ensure absorption
    2. Up to 10% of patients still may not absorb Mepron
  6. Efficacy: HIV
    1. Not as clinically active as Bactrim
    2. Pneumocystis Pneumonia treatment Failure rate: 17%
      1. Contrast with 6% for Bactrim
  7. Adverse effects
    1. Less dose-limiting adverse reactions than Bactrim
      1. Atovaquone: 7%
      2. Bactrim: 20%
    2. Rash
    3. Abdominal Pain
    4. Nausea or Vomiting
    5. Diarrhea
    6. Headache
    7. Mild Liver Function Test abnormalities
  8. Drug Interactions: Reduced plasma levels of Atovaquone
    1. Tetracycline
    2. Metoclopramide (Reglan)
    3. Rifampin
  9. References
    1. (2000) Med Lett Drugs Ther 42(1093):109-12 [PubMed]
Medication Costs
atovaquone (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
ATOVAQUONE 750 MG/5 ML SUSP Generic $2.62 per ml
ATOVAQUONE-PROGUANIL 250-100 MG TABLET Generic $4.14 each
mepron (on 1/1/2017 at Medicaid.Gov Pharmacy Drug pricing)
MEPRON 750 MG/5 ML SUSPENSION Generic $2.62 per ml
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Atovaquone (C0165603)

Definition (NCI) A synthetic hydroxynaphthoquinone with antiprotozoal activity. Atovoquone blocks the mitochondrial electron transport at complex III of the respiratory chain of protozoa, thereby inhibiting pyrimidine synthesis, preventing DNA synthesis and leading to protozoal death.
Definition (CSP) broad-spectrum antiparasitic drug found to be active against Pneumocystis carinii pneumonia in AIDS patients.
Definition (MSH) A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D053626
SnomedCT 391793007, 108718008, 386899002
LNC LP94829-6, MTHU031993
English atovaquone, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, Atovaquone, 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione, atovaquone (medication), ATOVAQUONE, Atovaquone [Chemical/Ingredient], Atovaquone - chemical, Atovaquone - chemical (substance), Atovaquone (product), Atovaquone (substance)
Portuguese Atovaquona
Spanish Atovacuona, Atovaquona, atovacuona (producto), atovacuona (sustancia), atovacuona
Russian АТОВАКОН, ATOVAKON
Italian Atovaquone
German Atovaquon, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinon, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinon
French Atovaquone, 2-(4-(4'-Chlorophényl)cyclohexyl)-3-hydroxy-1,4-naphtoquinone
Czech 2-(trans-4-(4-chlorfenyl)cyklohexyl)-3-hydroxy-1,4-naftochinon, atovachon, 2-(4-(4'-chlorfenyl)cyklohexyl)-3-hydroxy-1,4-naftochinon
Finnish Atovakvoni
Japanese アトバコン
Swedish Atovakvon
Polish Atowakon
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Mepron (C0378468)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D053626
English Mepron, Wellvone, Glaxo Wellcome brand of atovaquone, GlaxoSmithKline brand of atovaquone, atovaquone GlaxoSmithKline brand, mepron
German Wellvone, Mepron
French Malarone, Wellvone, Mepron
Czech Mepron
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Malarone (C0595490)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C109496
English Malarone, malarone, GlaxoSmithKline brand of atovaquone-proguanil
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree